The role of Bcl-x(L) protein in nucleotide excision repair-facilitated cell protection against cisplatin-induced apoptosis

DNA and Cell Biology

Volumn 28, Issue 6, 2009, Pages 285-294

  Lomonaco, Stephanie L ^a   Xu, Xiaoxin S ^a   Wang, Gan ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NUCLEIC ACID BINDING PROTEIN; PROTEIN BCL XL; UNCLASSIFIED DRUG; XERODERMA PIGMENTOSUM GROUP A PROTEIN; XERODERMA PIGMENTOSUM GROUP G PROTEIN; ALKYLATING AGENT; BCL2L1 PROTEIN, HUMAN; DNA BINDING PROTEIN; DNA EXCISION REPAIR PROTEIN ERCC 5; DNA EXCISION REPAIR PROTEIN ERCC-5; ENDONUCLEASE; NUCLEAR PROTEIN; PROTEIN BCL X; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; XPA PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CELL NUCLEUS; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; CYTOPLASM; EXCISION REPAIR; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ACTIVE TRANSPORT; BIOSYNTHESIS; CELL LINE; DNA DAMAGE; DNA REPAIR; DRUG ANTAGONISM; DRUG EFFECT; FIBROBLAST; GENETICS; PATHOLOGY; PHYSIOLOGY; XERODERMA PIGMENTOSUM;

ACTIVE TRANSPORT, CELL NUCLEUS; ALKYLATING AGENTS; APOPTOSIS; BCL-X PROTEIN; CELL LINE; CISPLATIN; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; ENDONUCLEASES; FIBROBLASTS; HUMANS; NF-KAPPA B; NUCLEAR PROTEINS; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; XERODERMA PIGMENTOSUM; XERODERMA PIGMENTOSUM GROUP A PROTEIN;

EID: 66949142175     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2008.0815     Document Type: Article

References (63)

1. Bae, J., Hsu, S.Y., Leo, C.P., Zell, K., and Hsueh, A.J. (2001). Underphosphorylated BAD interacts with diverse anti-apoptotic Bcl-2 family proteins to regulate apoptosis. Apop-tosis 6, 319-330.
2. Barber, L.J., Ward, T.A., Hartley, J.A., and McHugh, P.J. (2005). DNA interstrand cross-link repair in the Saccharomyces cerevisiae cell cycle: overlapping roles for PSO2 (SNM1) with MutS factors and EXO1 during S phase. Mol Cell Biol 25, 2297-2309.
3. Beere, H.M. (2005). Death versus survival: functional interaction between the apoptotic and stress-inducible heat shock protein pathways. J Clin Invest 115, 2633-2639.
4. Campbell, K.J., Witty, J.M., Rocha, S., and Perkins, N.D. (2006). Cisplatin mimics ARF tumor suppressor regulation of RelA (p65) nuclear factor-kappaB transactivation. Cancer Res 66, 929- 935.
5. Chanvorachote, P., Nimmannit, U., Stehlik, C., Wang, L., Jiang, B.H., Ongpipatanakul, B., and Rojanasakul, Y. (2006). Nitric oxide regulates cell sensitivity to cisplatin-induced apoptosis through S-nitrosylation and inhibition of Bcl-2 ubiquitination. Cancer Res 66, 6353-6360.
6. Chen, Z., Xu, X.S., Harrison, J., and Wang, G. (2004). Defining the function of xeroderma pigmentosum group F protein in psoralen interstrand cross-link mediated DNA repair and mutagenesis. Biochem J 379:71-78.
7. Chen, Z.W., Xu, X.S., Yang, J., and Wang, G. (2003). Defining the function of XPC protein in psoralen and cisplatin-mediated DNA repair and mutagenesis. Carcinogenesis 24, 1111-1121.
8. Chen, Z., Yang, J., Wang, G., Song, B., Li, J., and Xu, Z. (2007). Attenuated expression of xeroderma pigmentosum group C is associated with critical events in human bladder cancer car-cinogenesis and progression. Cancer Res 67, 4578-4585.
9. Cheng, W.H., Kusumoto, R., Opresko, P.L., Sui, X., Huang, S., Nicolette, M.L., Paull, T.T., Campisi, J., Seidman, M., and Bohr, V.A. (2006). Collaboration of Werner syndrome protein and BRCA1 in cellular responses to DNA interstrand crosslinks. Nucleic Acids Res 34, 2751-2760.
10. Chipuk, J.E., Kuwana, T., Bouchier-Hayes, L., Droin, N.M., Newmeyer, D.D., Schuler, M., and Green, D.R. (2004). Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303, 1010-1014.
11. Chowdhury, I., Tharakan, B., and Bhat, G.K. (2006). Current concepts in apoptosis: the physiological suicide program revisited. Cell Mol Biol Lett 11, 506-525.
12. Colton, S.L., Xu, X.S., Wang, A.Y., and Wang, G. (2006). The involvement of Ataxia-telangiectasia mutated protein activation in nucleotide excision repair-facilitated cell survival with cisplatin treatment. J Biol Chem 281, 27117-27125.
13. de Laat, W.L., Sijbers, A.M., Odijk, H., Jaspers, N.G., and Hoeijmakers, J.H. (1998). Mapping of interaction domains between human repair proteins ERCC1 and XPF. Nucleic Acids Res 26, 4146-4152.
14. De Silva, I.U., McHugh, P.J., Clingen, P.H., and Hartley, J.A. (2000). Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand cross-links in mammalian cells. Mol Cell Biol 20, 7980-7990.
15. Di Stefano, V., Rinaldo, C., Sacchi, A., Soddu, S., and D'Orazi, G. (2004). Homeodomain-interacting protein kinase-2 activity and p53 phosphorylation are critical events for cisplatin-mediated apoptosis. Exp Cell Res 293, 311-320.
16. Evans, E., Moggs, J.G., Hwang, J.R., Egly, J.M., and Wood, R.D. (1997). Mechanism of open complex and dual incision formation by human nucleotide excision repair factors. EMBO J 16, 6559-6573.
17. Friedberg, E.C., Walker, G.C., and Siede, W. (1995). DNA Repair and Mutagenesis, first edition (ASM published, Washington, DC).
18. Friedberg, E.C., Walker, G.C., Siede, W., Wood, R.D., Schultz, R.A., and Ellenberger, T. (2006). DNA Repair and Mutagenesis, second edition (ASM Press, Washington, DC).
19. Hanawalt, P.C. (1994). Transcription-coupled repair and human disease. Science 266, 1957-1958.
20. Hanawalt, P.C. (2002). Subpathways of nucleotide excision repair and their regulation. Oncogene 21:8949-8956.
21. Hey, T., Lipps, G., Sugasawa, K., Iwai, S., Hanaoka, F., and Krauss, G. (2002). The XPC-HR23B complex displays high affinity and specificity for damaged DNA in a true-equilibrium fluorescence assay. Biochemistry 41, 6583-6587.
22. Houtgraaf, J.H., Versmissen, J., and van der Giessen, W.J. (2006). A concise review of DNA damage checkpoints and repair in mammalian cells. Cardiovasc Revasc Med 7, 165-172.
23. Huerta-Yepez, S., Vega, M., Jazirehi, A., Garban, H., Hongo, F., Cheng, G., and Bonavida, B. (2004). Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-kappa B and inhibition of Bcl-xl expression. Oncogene 23, 4993-5003.
24. Janicijevic, A., Sugasawa, K., Shimizu, Y., Hanaoka, F., Wijgers, N., Djurica, M., Hoeijmakers, J.H., and Wyman, C. (2003). DNA bending by the human damage recognition complex XPC-HR23B. DNA Repair 2, 325-336.
25. Jeffers, J.R., Parganas, E., Lee, Y., Yang, C., Wang, J., Brennan, J., MacLean, K.H., Han, J., Chittenden, T., Ihle, J.N., McKinnon, P.J., Cleveland, J.L., and Zambetti, G.P. (2003). Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 4, 321-328.
26. Jeggo, P.A., and Lobrich, M. (2006). Contribution of DNA repair and cell cycle checkpoint arrest to the maintenance of genomic. DNA Repair 5, 1192-1198.
27. Jiang, M., Yi, X., Hsu, S., Wang, C.Y., and Dong, Z. (2004). Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity. Am J Physiol Renal Physiol 287, F1140-F1147.
28. Koberle, B., Masters, J.R., Hartley, J.A., and Wood, R.D. (1999). Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours. Curr Biol 9, 273-276.
29. Kuwana, T., Mackey, M.R., Perkins, G., Ellisman, M.H., Latter-ich, M., Schneiter, R., Green, D.R., and Newmeyer, D.D. (2002). Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 111, 331-342.
30. Laine, J.P., and Egly, J.M. (2006). Initiation of DNA repair mediated by a stalled RNA polymerase IIO. EMBO J 25, 387-397.
31. Lalle, P., Nouspikel, T., Constantinou, A., Thorel, F., and Clarkson, S.G. (2002). The founding members of xeroderma pigmentosum group G produce XPG protein with severely impaired endonuclease activity. J Invest Dermatol 118, 344-351.
32. Le Bras, M., Rouy, I., and Brenner, C. (2006). The modulation of inter-organelle cross-talk to control apoptosis. Med Chem 2, 1-12.
33. Leu, J.I., Dumont, P., Hafey, M., Murphy, M.E., and George, D.L. (2004). Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat Cell Biol 6, 443-450.
34. Liu, X., Lao, Y., Yang, I.Y., Hecht, S.S., and Moriya, M. (2006). Replication-coupled repair of crotonaldehyde/acetaldehyde-induced guanine-guanine interstrand cross-links and their mutagenicity. Biochemistry 45, 12898-12905.
35. Matsumura, Y., Nishigori, C., Yagi, T., Imamura, S., and Takebe, H. (1998). Characterization of molecular defects in xeroderma pigmentosum group F in relation to its clinically mild symptoms. Hum Mol Genet 7, 969-974.
36. Ming, L., Wang, P., Bank, A., Yu, J., and Zhang, L. (2006). PUMA dissociates Bax and Bcl-X(L) to induce apoptosis in colon cancer cells. J Biol Chem 281, 16034-16042.
37. Mori, N., Fujii, M., Cheng, G., Ikeda, S., Yamasaki, Y., Yamada, Y., Tomonaga, M., and Yamamoto, N. (2001). Human T-cell leukemia virus type I tax protein induces the expression of anti-apoptotic gene Bcl-xL in human T-cells through nuclear factor-kappaB and c-AMP responsive element binding protein pathways. Virus Genes 22, 279-287.
38. Mujoo, K., Watanabe, M., Nakamura, J., Khokhar, A.R., and Siddik, Z.H. (2003). Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents. J Cancer Res Clin Oncol 129, 709-718.
39. Nojima, K., Hochegger, H., Saberi, A., Fukushima, T., Kikuchi, K., Yoshimura, M., Orelli, B.J., Bishop, D.K., Hirano, S., Ohzeki, M., Ishiai, M., Yamamoto, K., Takata, M., Arakawa, H., Buerstedde, J.M., Yamazoe, M., Kawamoto, T., Araki, K., Takahashi, J.A., Hashimoto, N., Takeda, S., and Sonoda, E. (2005). Multiple repair pathways mediate tolerance to chemotherapeutic cross-linking agents in vertebrate cells. Cancer Res 65, 11704-11711.
40. Perry, M.C. (2001). The Chemotherapy Source Book (Lippincott Williams & Wilkins). Philadelphia, PA.
41. Pommier, Y., Sordet, O., Antony, S., Hayward, R.L., and Kohn, K.W. (2004). Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks. Oncogene 23, 2934- 2949.
42. Reed, J.C. (2006). Proapoptotic multidomain Bcl-2/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities. Cell Death Differ. 13, 1378-1386.
43. Rocha, S., Garrett, M.D., Campbell, K.J., Schumm, K., and Perkins, N.D. (2005). Regulation of NF-kappaB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor. EMBO J 24, 1157-1169.
44. Rocha, S., and Perkins, N.D. (2005). ARF the integrator: linking NF-kappaB, p53 and checkpoint kinases. Cell Cycle 4, 756- 759.
45. Sancar, A., Lindsey-Boltz, L.A., Unsal-Kaccmaz, K., and Linn, S. (2004). Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 73, 39-85.
46. Sarkar, S., Davies, A.A., Ulrich, H.D., and McHugh, P.J. (2006). DNA interstrand crosslink repair during G1 involves nucleo-tide excision repair and DNA polymerase zeta. EMBO J 25, 1285-1194.
47. Sarker, A.H., Tsutakawa, S.E., Kostek, S., Ng, C., Shin, D.S., Peris, M., Campeau, E., Tainer, J.A., Nogales, E., and Cooper, P.K. (2005). Recognition of RNA polymerase II and transcription bubbles by XPG, CSB, and TFIIH: insights for transcription-coupled repair and Cockayne syndrome. Mol Cell 20, 187-198.
48. Satoh, M.S., and Hanawalt, P.C. (1997). Competent transcription initiation by RNA polymerase II in cell-free extracts from xeroderma pigmentosum groups B and D in an optimized RNA transcription assay. Biochim Biophys Acta 1354, 241- 251.
49. Selvakumaran, M., Pisarcik, D.A., Bao, R., Yeung, A.T., and Hamilton, T.C. (2003). Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines. Cancer Res 63, 1311-1316.
50. Shen, X., Jun, S., O'Neal, L.E., Sonoda, E., Bemark, M., Sale, J.E., and Li, L. (2006). EV3 and REV1 play major roles in recombination-independent repair of DNA interstrand cross-links mediated by monoubiquitinated proliferating cell nuclear antigen (PCNA). J Biol Chem 281, 13869-13872.
51. Shivji, M.K., Podust, V.N., Hubscher, U., and Wood, R.D. (1995). Nucleotide excision repair DNA synthesis by DNA polymer-ase epsilon in the presence of PCNA, RFC, and RPA. Biochemistry 34, 5011-5017.
52. Volker, M., Mone, M.J., Karmakar, P., van Hoffen, A., Schul, W., Vermeulen, W., Hoeijmakers, J.H., van Driel, R., van Zeeland, A.A., and Mullenders, L.H. (2001). Sequential assembly of the nucleotide excision repair factors in vivo. Mol Cell 8, 213-224.
53. Wakasugi, M., and Sancar, A. (1999). Order of assembly of human DNA repair excision nuclease. J Biol Chem 274, 18759- 18768.
54. Wang, G., Chuang, L., Zhang, X., Colton, S., Dombkowski, A., Reiners, J., Diakiw, A., and Xu, X.S. (2004). The initiative role of XPC protein in cisplatin DNA damaging treatment-mediated cell cycle regulation. Nucleic Acids Res 32, 2231-2240.
55. Wei, M.C., Zong, W.X., Cheng, E.H., Lindsten, T., Panoutsakopoulou, V., Ross, A.J., Roth, K.A., MacGregor, G.R., Thompson, C.B., and Korsmeyer, S.J. (2001). Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292, 727-730.
56. Wu, Y.H., Tsai Chang, J.H., Cheng, Y.W., Wu, T.C., Chen, C.Y., and Lee, H. (2007). Xeroderma pigmentosum group C gene expression is predominantly regulated by promoter hypermethylation and contributes to p53 mutation in lung cancers. Oncogene 26, 4761-4773.
57. Wu, Z.H., Shi, Y., Tibbetts, R.S., and Miyamoto, S. (2006). Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli. Science 311, 1141- 1146.
58. Wuerzberger-Davis, S.M., Nakamura, Y., Seufzer, B.J., and Miyamoto, S. (2007). NF-kappaB activation by combinations of NEMO SUMOylation and ATM activation stresses in the absence of DNA damage. Oncogene 26, 641-651.
59. Yang, J., Liu, X., Bhalla, K., Kim, C.N., Ibrado, A.M., Cai, J., Peng, T.I., Jones, D.P., and Wang, X. (1997). Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275, 1129-1132.
60. Yip, H.T., Chopra, R., Chakrabarti, R., Veena, M.S., Rama-murthy, B., Srivatsan, E.S., and Wang, M.B. (2006). Cisplatin-induced growth arrest of head and neck cancer cells correlates with increased expression of p16 and p53. Arch Otolaryngol Head Neck Surg 32, 317-326.
61. Zheng, H., Wang, X., Legerski, R.J., Glazer, P.M., and Li, L. (2006). Repair of DNA interstrand cross-links: interactions between homology-dependent and homology-independent pathways. DNA Repair 5, 566-574.
62. Zheng, H., Wang, X., Warren, A.J., Legerski, R.J., Nairn, R.S., Hamilton, J.W., and Li, L. (2003). Nucleotide excision repair-and polymerase eta-mediated error-prone removal of mito-mycin C interstrand cross-links. Mol Cell Biol 23, 754-761.
63. Zinkel, S., Gross, A., and Yang, E. (2006). BCL2 family in DNA damage and cell cycle control. Cell Death Differ 13, 1351-1359.